Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00418171 · ClinicalTrials.gov registry record · Phase 4
Large Simple Trial (LST) Of Cardiovascular Safety Of Ziprasidone And Olanzapine- (Zodiac)
A Phase 4 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 4
- Development phase
- 18,239
- Enrollment target
NCT00418171: Completed Phase 4 study, sponsored by Pfizer.
NCT00418171 is a Phase 4 study that has completed, run by Pfizer. The registered enrollment target is 18,239 participants, above the 516-participant average among 9,235 other Phase 4 trials with a reported enrollment target (3435% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00418171, a Phase 4 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 18,239 participants
- Enrollment target
Study Summary
The primary objective of the study is to estimate the relative incidence among users of ziprasidone and olanzapine of non-suicide mortality.
Interventions
- DRUG Olanzapine
- DRUG Ziprasidone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18,239 participants |
| Start Date | 2002-02 |
| Est. Completion | 2007-04 |
| Phase | Phase 4 |
What the finished NCT00418171 record still lists
NCT00418171 is an interventional study that assigns participants to a tested intervention. Its 18,239 participants enrollment target places it among the larger protocols in the corpus, above the 516-participant average among 9,235 other Phase 4 trials with a reported enrollment target (3435% higher).
The record links to 0 conditions, and to 2 interventions - of which Olanzapine is the first listed.
NCT00418171 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00418171 about?
NCT00418171 is a clinical study titled "Large Simple Trial (LST) Of Cardiovascular Safety Of Ziprasidone And Olanzapine- (Zodiac)". The primary objective of the study is to estimate the relative incidence among users of ziprasidone and olanzapine of non-suicide mortality.
What is the current status of trial NCT00418171?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 18,239 participants. The study started on 2002-02. Estimated completion is 2007-04.
What interventions are being tested in trial NCT00418171?
The interventions under investigation include: Olanzapine (DRUG), Ziprasidone (DRUG).
Who is sponsoring clinical trial NCT00418171?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00418171's enrollment target sits among peer trials
18,239 6th of 2000 higher than 1,995 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04110522 · 18,000 participants · NA
Psoriatic Arthritis D2P Screening
- NCT05513833 · 18,000 participants · NA
School Screening and Telemedicine Specialty Referral to Address Childhood Hearing Loss in Rural Kentucky
- NCT06802224 · 18,000 participants · Phase 4
The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery
- NCT04372875 · 18,500 participants · NA
Health Information Technology to Reduce Disparities in Adolescent Health Outcomes: A Pragmatic Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia